Singulair And Suicidality: FDA Finds No Immediate Link, But Review Continues
Executive Summary
FDA is continuing to review a possible relationship between the use of Merck's Singulair (montelukast) and an increased risk of suicidality despite finding no association so far between leukotriene pathway drugs and mood behaviors